2023. Effectiveness and Safety After a Switch to Tildrakizumab: A Real World Multicenter Italian Study in Psoriasis. Dermatology Practical & Conceptual. 13, 4 (Oct. 2023), e2023215. DOI:https://doi.org/10.5826/dpc.1304a215.